AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Antibodies against MAEBL ligand domains inhibit sporozoite development.

Vaccine Weekly

| August 11, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 AUG 11 - (NewsRx.com & NewsRx.net) -- Antibodies against MAEBL ligand domains M1 and M2 inhibit sporozoite development in vitro.

"MAEBL is a type 1 membrane protein that is implicated in the merozoite invasion of erythrocytes and sporozoite invasion of mosquito salivary glands. This apical organelle protein is structurally similar to the ebl erythrocyte binding proteins, such as EBA-175, except that the tandem ligand domains of MAEBL are similar to part of the extracellular domain of apical membrane antigen 1 and not the Duffy binding-like domain," scientists writing in the journal Infection and Immunity report.

"Although midgut and salivary gland sporozoites are morphologically similar, salivary gland sporozoites undergo a period of new gene expression after infecting the salivary glands, display distinct phenotypic differences, and are more infectious for the mammalian host," reported Peter Preiser at the National Institute for Medical Research in London, England, and collaborators throughout the world. "The objectives of this project were to determine the molecular form of MAEBL in the infectious salivary gland sporozoites and whether the ligand has a role in the sporozoite development to exoerythrocytic stages in hepatocytes."

"We determined that MAEBL is newly expressed in salivary gland sporozoites and in a form distinct from what is present in the midgut sporozoites or present in erythrocytic stages," stated the researchers. "Both ligand domains (M1 and M2) were expressed as part of a ...

Related articles from newspapers, magazines, journals, and more
Metabolic changes of the malaria parasite during the transition from the human...
Magazine article from: Annual Review of Microbiology Lang-Unnasch, N. Murphy, A.D. January 1, 1998 700+ words
...mosquito factors in the blood meal, and is completely absent outside the midgut at the site of oocyst and sporozoite development. Such differences suggest that the metabolic requirements and capabilities of the parasite are likely to change...
New findings from University of Agriculture describe advances in malaria.
Newspaper article from: Biotech Week August 27, 2008 700+ words
...Biochemical Parasitology (Disruption of the Plasmodium berghei 2-Cys peroxiredoxin TPx-1 gene hinders the sporozoite development in the vector mosquito. Molecular and Biochemical Parasitology, 2008;159(2):142-145). For more...
Researchers from McMaster University provide details of new studies and...
Newspaper article from: Blood Weekly April 23, 2009 700+ words
...and -4 are cleaved in their first extracellular domains after R-41 and R-47, respectively, to expose the tethered ligand domains of PAR-1 and -4," researchers in Hamilton, Canada report (see also Proteomics). "Since soybean trypsin inhibitor...
Protease-activated receptors: contribution to physiology and disease.
Magazine article from: Physiological Reviews Ossovskaya, Valeria S. Bunnett, Nigel W. April 1, 2004 700+ words
...ligands interact with extracellular domains to initiate signal transduction B. Structure-activity relations of tethered ligand domains C. PARs activate multiple signaling cascades IV. Protease-Activated Receptors: Termination of the Signal A. Cell...
For more facts and information, see all results

Source: HighBeam Research, Antibodies against MAEBL ligand domains inhibit sporozoite...

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA